Gonadotropin-releasing hormone analogs

Understanding advantages and limitations

Pratap Kumar, Alok Sharma

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Pituitary stimulation with pulsatile gonadotropin-releasing hormone (GnRH) analogs induces both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Pituitary gonadotropin secretions are blocked upon desensitization when a continuous GnRH stimulus is provided by means of an agonist or when the pituitary receptors are occupied with a competitive antagonist. GnRH antagonists were not available originally; therefore, prolonged daily injections of agonist with its desensitizing effect were used. Today, single-and multiple-dose injectable antagonists are also available to block the LH surge and thus to cause desensitization. This review provides an overview of the use of GnRH analogs which is potent therapeutic agents that are considerably useful in a variety of clinical indications from the past to the future with some limitations. These indications include management of endometriosis, uterine leiomyomas, hirsutism, dysfunctional uterine bleeding, premenstrual syndrome, assisted reproduction, and some hormone-dependent tumours, other than ovulation induction.

Original languageEnglish
Pages (from-to)170-174
Number of pages5
JournalJournal of Human Reproductive Sciences
Volume7
Issue number3
DOIs
Publication statusPublished - 01-01-2014

Fingerprint

Gonadotropin-Releasing Hormone
Luteinizing Hormone
Pituitary Gonadotropins
Hormone Antagonists
Premenstrual Syndrome
Hirsutism
Metrorrhagia
Injections
Ovulation Induction
Leiomyoma
Follicle Stimulating Hormone
Endometriosis
Reproduction
Hormones
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine

Cite this

@article{ce0be3655fd248b4b429f4ca1db36e24,
title = "Gonadotropin-releasing hormone analogs: Understanding advantages and limitations",
abstract = "Pituitary stimulation with pulsatile gonadotropin-releasing hormone (GnRH) analogs induces both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Pituitary gonadotropin secretions are blocked upon desensitization when a continuous GnRH stimulus is provided by means of an agonist or when the pituitary receptors are occupied with a competitive antagonist. GnRH antagonists were not available originally; therefore, prolonged daily injections of agonist with its desensitizing effect were used. Today, single-and multiple-dose injectable antagonists are also available to block the LH surge and thus to cause desensitization. This review provides an overview of the use of GnRH analogs which is potent therapeutic agents that are considerably useful in a variety of clinical indications from the past to the future with some limitations. These indications include management of endometriosis, uterine leiomyomas, hirsutism, dysfunctional uterine bleeding, premenstrual syndrome, assisted reproduction, and some hormone-dependent tumours, other than ovulation induction.",
author = "Pratap Kumar and Alok Sharma",
year = "2014",
month = "1",
day = "1",
doi = "10.4103/0974-1208.142476",
language = "English",
volume = "7",
pages = "170--174",
journal = "Journal of Human Reproductive Sciences",
issn = "0974-1208",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

Gonadotropin-releasing hormone analogs : Understanding advantages and limitations. / Kumar, Pratap; Sharma, Alok.

In: Journal of Human Reproductive Sciences, Vol. 7, No. 3, 01.01.2014, p. 170-174.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Gonadotropin-releasing hormone analogs

T2 - Understanding advantages and limitations

AU - Kumar, Pratap

AU - Sharma, Alok

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Pituitary stimulation with pulsatile gonadotropin-releasing hormone (GnRH) analogs induces both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Pituitary gonadotropin secretions are blocked upon desensitization when a continuous GnRH stimulus is provided by means of an agonist or when the pituitary receptors are occupied with a competitive antagonist. GnRH antagonists were not available originally; therefore, prolonged daily injections of agonist with its desensitizing effect were used. Today, single-and multiple-dose injectable antagonists are also available to block the LH surge and thus to cause desensitization. This review provides an overview of the use of GnRH analogs which is potent therapeutic agents that are considerably useful in a variety of clinical indications from the past to the future with some limitations. These indications include management of endometriosis, uterine leiomyomas, hirsutism, dysfunctional uterine bleeding, premenstrual syndrome, assisted reproduction, and some hormone-dependent tumours, other than ovulation induction.

AB - Pituitary stimulation with pulsatile gonadotropin-releasing hormone (GnRH) analogs induces both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Pituitary gonadotropin secretions are blocked upon desensitization when a continuous GnRH stimulus is provided by means of an agonist or when the pituitary receptors are occupied with a competitive antagonist. GnRH antagonists were not available originally; therefore, prolonged daily injections of agonist with its desensitizing effect were used. Today, single-and multiple-dose injectable antagonists are also available to block the LH surge and thus to cause desensitization. This review provides an overview of the use of GnRH analogs which is potent therapeutic agents that are considerably useful in a variety of clinical indications from the past to the future with some limitations. These indications include management of endometriosis, uterine leiomyomas, hirsutism, dysfunctional uterine bleeding, premenstrual syndrome, assisted reproduction, and some hormone-dependent tumours, other than ovulation induction.

UR - http://www.scopus.com/inward/record.url?scp=84908397909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908397909&partnerID=8YFLogxK

U2 - 10.4103/0974-1208.142476

DO - 10.4103/0974-1208.142476

M3 - Review article

VL - 7

SP - 170

EP - 174

JO - Journal of Human Reproductive Sciences

JF - Journal of Human Reproductive Sciences

SN - 0974-1208

IS - 3

ER -